Increased Serum Levels of Tumor Necrosis Factor α Precede Major Complications of Bone Marrow Transplantation
Holler, E., Kolb, H.J., Möller, A., Kempeni, J., Liesenfeld, S., Pechumer, H., Lehmacher, W., Ruckdeschel, G., Gleixner, B., Riedner, C., Ledderose, G., Brehm, G., Mittermüller, J., Wilmanns, W.
Published in Blood (15.02.1990)
Published in Blood (15.02.1990)
Get full text
Journal Article
Modulation of Acute Graft-Versus-Host Disease After Allogeneic Bone Marrow Transplantation by Tumor Necrosis Factor α (TNFα) Release in the Course of Pretransplant Conditioning: Role of Conditioning Regimens and Prophylactic Application of a Monoclonal Antibody Neutralizing Human TNFα (MAK 195F)
Holler, E., Kolb, H.J., Mittermiiller, J., Kaul, M., Ledderose, G., Duell, Th, Seeber, B., Schleuning, M., Hintermeier-Knabe, R., Ertl, B., Kempeni, J., Wilmanns, W.
Published in Blood (01.08.1995)
Published in Blood (01.08.1995)
Get full text
Journal Article
Rapid alleviation of signs and symptoms of rheumatoid arthritis with intravenous or subcutaneous administration of adalimumab in combination with methotrexate
Rau, R, Simianer, S, van Riel, PLCM, van de Putte, LBA, Krüger, K, Schattenkirchner, M, Allaart, CF, Breedveld, FC, Kempeni, J, Beck, K, Kupper, H
Published in Scandinavian journal of rheumatology (01.05.2004)
Published in Scandinavian journal of rheumatology (01.05.2004)
Get full text
Journal Article
Standardizing assessment of adverse effects in rheumatology clinical trials. Status of OMERACT Toxicity Working Group March 2000: towards a common understanding of comparative toxicity/safety profiles for antirheumatic therapies
Woodworth, T G, Furst, D E, Strand, V, Kempeni, J, Fenner, H, Lau, C S, Miller, F, Day, R, Lipani, J, Brooks, P
Published in Journal of rheumatology (01.05.2001)
Get more information
Published in Journal of rheumatology (01.05.2001)
Journal Article
Phase I study of recombinant human tumor necrosis factor α in advanced malignant disease
MORITZ, T, NIEDERLE, N, BAUMANN, J, MAY, D, KURSCHEL, E, OSIEKA, R, KEMPENI, J, SCHLICK, E, SCHMIDT, C. G
Published in Cancer Immunology, Immunotherapy : CII (01.06.1989)
Published in Cancer Immunology, Immunotherapy : CII (01.06.1989)
Get full text
Journal Article
Kinetics of soluble TNF-receptors and soluble adhesion molecules ICAM-1, E-selectin and VCAM-1 under systemic rhTNF alpha therapy
Boehme, M W, Waldherr, R, Kist, A, Riedl, S, Walter-Kirst, R, Kempeni, J, Raeth, U
Published in European journal of clinical investigation (01.05.1996)
Published in European journal of clinical investigation (01.05.1996)
Get more information
Journal Article
A single dose, placebo controlled study of the fully human anti-tumor necrosis factor-alpha antibody adalimumab (D2E7) in patients with rheumatoid arthritis
den Broeder, Alfons, van de Putte, Leo, Rau, Rolf, Schattenkirchner, Manfred, Van Riel, Piet, Sander, Oliver, Binder, Christina, Fenner, Helmut, Bankmann, Yvonne, Velagapudi, Raja, Kempeni, Joachim, Kupper, Hartmut
Published in Journal of rheumatology (01.11.2002)
Get more information
Published in Journal of rheumatology (01.11.2002)
Journal Article
Treatment of aGVHD with OKT3: clinical outcome and side-effects associated with release of TNF alpha
Gleixner, B, Kolb, H J, Holler, E, Liesenfeld, S, Riedner, C, Hiller, E, Seeber, C, Kempeni, J, Möller, A, Knabe, H
Published in Bone marrow transplantation (Basingstoke) (01.08.1991)
Get full text
Published in Bone marrow transplantation (Basingstoke) (01.08.1991)
Journal Article
Randomized, placebo-controlled trial of the anti-tumor necrosis factor antibody fragment afelimomab in hyperinflammatory response during severe sepsis: The RAMSES Study
Reinhart, K, Menges, T, Gardlund, B, Harm Zwaveling, J, Smithes, M, Vincent, J L, Tellado, J M, Salgado-Remigio, A, Zimlichman, R, Withington, S, Tschaikowsky, K, Brase, R, Damas, P, Kupper, H, Kempeni, J, Eiselstein, J, Kaul, M
Published in Critical care medicine (01.04.2001)
Published in Critical care medicine (01.04.2001)
Get more information
Journal Article
Assessment of the safety and efficacy of the monoclonal anti-tumor necrosis factor antibody-fragment, MAK 195F, in patients with sepsis and septic shock: a multicenter, randomized, placebo-controlled, dose-ranging study
Reinhart, K, Wiegand-Löhnert, C, Grimminger, F, Kaul, M, Withington, S, Treacher, D, Eckart, J, Willatts, S, Bouza, C, Krausch, D, Stockenhuber, F, Eiselstein, J, Daum, L, Kempeni, J
Published in Critical care medicine (01.05.1996)
Published in Critical care medicine (01.05.1996)
Get more information
Journal Article
Phase I study of recombinant human tumor necrosis factor ? in advanced malignant disease
Moritz, T., Niederle, N., Baumann, J., May, D., Kurschel, E., Osieka, R., Kempeni, J., Schlick, E., Schmidt, C.G.
Published in Cancer Immunology Immunotherapy (01.06.1989)
Published in Cancer Immunology Immunotherapy (01.06.1989)
Get full text
Journal Article
Low Incidence of Transplant-Related Complications in Patients with Chronic Release of Tumor Necrosis Factor-Alpha before Admission to Bone Marrow Transplantation: A Clinical Correlate of Cytokine Desensitization?
Holler, E., Hintermeier-Knabe, R., Kolb, H.J., Kempeni, J., Möller, A., Liesenfeld, S., Daum, L., Wilmanns, W.
Published in Pathobiology (Basel) (1991)
Published in Pathobiology (Basel) (1991)
Get full text
Journal Article
Effect of intraperitoneal recombinant human tumour necrosis factor alpha on malignant ascites
Räth, U, Kaufmann, M, Schmid, H, Hofmann, J, Wiedenmann, B, Kist, A, Kempeni, J, Schlick, E, Bastert, G, Kommerell, B
Published in European journal of cancer (1990) (1991)
Get more information
Published in European journal of cancer (1990) (1991)
Journal Article
Theranostic Mesoporous Silica Nanoparticles Biodegrade after Pro-Survival Drug Delivery and Ultrasound/Magnetic Resonance Imaging of Stem Cells
Kempen, Paul J., Greasley, Sarah, Parker, Kelly A., Campbell, Jos C., Chang, Huan-Yu, Jones, Julian R., Sinclair, Robert, Gambhir, Sanjiv S., Jokerst, Jesse V.
Published in Theranostics (2015)
Published in Theranostics (2015)
Get full text
Journal Article
Changes in skeletal muscle pO2 after administration of anti-TNF alpha-antibody in patients with severe sepsis: comparison to interleukin-6 serum levels, APACHE II, and Elebute scores
Boekstegers, P, Weidenhöfer, S, Zell, R, Holler, E, Kapsner, T, Redl, H, Schlag, G, Kaul, M, Kempeni, J, Werdan, K
Published in Shock (Augusta, Ga.) (01.04.1994)
Published in Shock (Augusta, Ga.) (01.04.1994)
Get more information
Journal Article